Yasemin Bakkal Temi

8PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Vision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 27, 2026
Prognostic and Predictive Significance of Body Mass Index in Locally Advanced Gastric Cancer Receiving Neoadjuvant Chemotherapy: A Retrospective Multicenter Cohort Study.

|Mar 28, 2026
EASIX Score as an Independent Prognostic Marker in De Novo Metastatic Pancreatic Cancer.

İlkay Çıtakkul, Yasemin Bakkal Temi, Zehra Aytin

|Mar 14, 2026
The Pretreatment Glucose-to-Lymphocyte Ratio as an Independent Prognostic Biomarker in Ovarian Cancer.

Ece Baydar, Yasemin Bakkal Temi, İlkay Çıtakkul

|Feb 27, 2026
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.

Baris Koksal, Hasan Cagri Yildirim, Deniz Can Guven

|Jan 10, 2026
Real-World Evaluation of the HELPP Score and CALLY Index for Preoperative Prognostic Stratification in Resectable Pancreatic Ductal Adenocarcinoma.

İlkay Çıtakkul, Umut Kefeli, Khatira Shukurova

|Jul 12, 2025
HALP-H Index as a Prognostic Biomarker for Predicting Pathological Complete Response in Early-Stage HER2-Positive Breast Cancer-A Multicenter Retrospective Cohort Study.

Mustafa Seyyar, Pervin Can Şancı, Tolga Köşeci

Pageof 2

Frequent Collaborators

4 joint publications

Devrim Çabuk

4 joint publications

Umut Kefeli

3 joint publications

Ece Baydar

2 joint publications

İlkay Çıtakkul